CKAP2L and neoplasm: In pathologic T stages, T3 and T4 ccRCC patients expressed higher CKAP2L levels (Figure 3B), especially in the tumor T4 stage, where CKAP2L was significantly higher than in the other three T stages (Figure 3B).